June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
|Articles|November 16, 2018
Mainstreaming corneal crosslinking
Erin D. Stahl, MD, discusses why it's important to diagnose and treat children with keratoconus at the earliest signs of development for successful outcomes during the AAO 2018 meeting in Chicago.
Advertisement
Erin D. Stahl, MD, discusses why it's important to diagnose and treat children with keratoconus at the earliest signs of development for successful outcomes during the AAO 2018 meeting in Chicago.
Advertisement
Related to this article
The RMAT designation opens the door to a faster development pathway for EO2002 as a minimally invasive alternative to corneal transplantation, while Emmecell also advances a cell therapy for geographic atrophy.
Patients with polyendocrine metabolic ovarian syndrome have higher ocular disease prevalence.
Length and width, not thickness, emerge as key drivers of higher-order aberrations.
A prospective pilot series finds Keraring implantation cuts refractive cylinder by 61% in non-ectatic corneas, opening a new conversation about ICRS indications.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
AAO 2026: Tinlarebant in Stargardt disease: Jacque Duncan, MD, on DRAGON results
2
AAO 2026: MCO-010 sustains vision gains in RP through 4 years
3
AAO 2026: Elegrobart reduces proptosis in active thyroid eye disease
4
AAO 2026: What the evidence really shows about nutrition and the eye
5